AbCellera Biologics Inc. ABCL Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s common stock?
- AbCellera Biologics Inc. (ABCL) reported common stock of $816.53M in Q1 2026.
- How has AbCellera Biologics Inc.'s common stock changed year-over-year?
- AbCellera Biologics Inc.'s common stock increased by 3.3% year-over-year, from $790.07M to $816.53M.
- What is the long-term trend for AbCellera Biologics Inc.'s common stock?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s common stock has grown at a 2.5% compound annual growth rate (CAGR), from $710.39M to $802.34M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).